Human Vaccines & Immunotherapeutics· 2026Q1

Pharmacovigilance signals of dupilumab among pediatric patients: A real‑world analysis based on the FAERS database

Xueqing Ma, Jiaojiao Fan, Ben Liu

1citations
Q1SCImago
2026year

Short summary

A real-world analysis of 44,593 pediatric reports from the FAERS database identified 93 potential safety signals for dupilumab, including elevated risks for vitiligo (ROR=10.46) and skin depigmentation (ROR=13.04).

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

ToxicologyPharmacology, Toxicology and Pharmaceutics